EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Meridian Bioscience's enterprise value is $1,444.5 Mil.
Meridian Bioscience's Revenue for the trailing twelve months (TTM) ended in Sep. 2022 was $333.0 Mil. Therefore, Meridian Bioscience's EV-to-Revenue for today is 4.34.
The historical rank and industry rank for Meridian Bioscience's EV-to-Revenue or its related term are showing as below:
VIVO's EV-to-Revenue is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: 3.11 * Ranked among companies with meaningful EV-to-Revenue only.
The historical data trend for Meridian Bioscience's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Meridian Bioscience's EV-to-Revenue
For the Diagnostics & Research subindustry, Meridian Bioscience's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Meridian Bioscience's EV-to-Revenue Distribution in the Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Meridian Bioscience's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where Meridian Bioscience's EV-to-Revenue falls into.
Meridian Bioscience's current Enterprise Value is $1,444.5 Mil.
Meridian Bioscience's Revenue for the trailing twelve months (TTM) ended in Sep. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $333.0 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Meridian Bioscience (NAS:VIVO) EV-to-Revenue Explanation
Meridian Bioscience's share price for today is $33.97.
Meridian Bioscience's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $7.51.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Meridian Bioscience EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of Meridian Bioscience's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Meridian Bioscience (Meridian Bioscience) Business Description
Meridian Bioscience Inc is an integrated life science company. It develops and distributes diagnostic tests and reagents, as well as biologic substances used by pharmaceutical and biotechnology companies. Its Diagnostics segment manufactures tests primarily for gastrointestinal, viral, respiratory, & parasitic infectious diseases. Its testing platforms include isothermal DNA amplification, rapid immunoassays, and enzyme-linked immunoassays. The Life sciences segment sells b-antigens, antibodies, and reagents in bulk to other diagnostic manufacturers, the agriculture industry, and researchers. It also manufactures proteins that biopharmaceutical companies use in new drugs and vaccines. The entity has a business presence in the US and other countries.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
VIVO has been successfully added to your 